IP Library Granted Patent US 10,898,607
Granted Patent B2
US 10,898,607 · App. 15/373,666 · Granted Jan 26, 2021

Bioerodible matrix for tissue involvement

Inventors: Dennis E. Van Epps (Goleta, CA); Thomas E. Powell (Santa Barbara, CA)
Assignee: ALLERGAN, INC.
A61L27/18A61F2/12A61L27/34A61L27/3604A61L27/3804A61L27/3834A61L27/3886A61L27/56A61L27/58A61L2420/06A61L2430/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,607
App. No.
15/373,666
Granted
Jan 26, 2021
Kind
B2
Abstract

Disclosed herein are polyurethane polymer matrices with a porosity of from about 20 microns to about 90 microns that are useful in promoting closure and protection of incision sites; supporting the lower pole position of breast implants; and providing a partial or complete covering of breast implants to provide a beneficial interface with host tissue and to reduce the potential for malpositioning or capsular contracture. The disclosed matrices can be seeded with mammalian cells.

Claims (10)

1. A medical implant comprising:

a breast prosthesis; and

a matrix on said breast prosthesis, the matrix comprising a resorbable or bioerodible polymer component and a cellular component, wherein the polymer component comprises polycaprolactone soft segments having an amorphous rubbery phase, the matrix having a porosity conducive to cell growth and capable of providing a beneficial interface between the prosthesis and host tissue to enhance biocompatibility and reducing the potential for malpositioning or capsular contracture.

2. The implant of claim 1 wherein the cellular component comprises stem cells.

3. The implant of claim 1 wherein the cellular component comprises adipose cells.

4. The implant of claim 1 wherein the cellular component comprises stem cells and adipose cells.

5. The implant of claim 1 wherein the matrix forms at least a partial covering on said breast prosthesis.

6. The implant of claim 1 wherein the matrix forms a complete covering of said breast prosthesis.

7. The implant of claim 1 wherein the matrix has a pore size diameter of about 10 to about 1000 microns.

8. The implant of claim 1 wherein the matrix has a pore size diameter of from about 20 to about 90 microns.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2017
From: VAN EPPS, DENNIS E.; POWELL, THOMAS E.
To: ALLERGAN, INC.
Reel/Frame 041110/0046 →
Continuity (5)
Continuation 14189457 · Feb 25, 2014
Continuation 13453886 · Apr 23, 2012
Division 12705177 · Feb 12, 2010
Provisional Application 61164344 · Mar 27, 2009
Related Publication 20170087273A1 · Mar 30, 2017